Yüklüyor......
Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
The Wnt pathway is a key element of bone remodeling; its activation stimulates bone formation and inhibits bone resorption. The discovery of sclerostin, a natural antagonist of the Wnt pathway, promoted the development of romosozumab, a human monoclonal antibody directed against sclerostin, as well...
Kaydedildi:
| Yayımlandı: | J Clin Med |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7694131/ https://ncbi.nlm.nih.gov/pubmed/33114755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113439 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|